TY  - BOOK
AU  - Batool F. Kirmani
AB  - Intractable epilepsy still remains the main issue despite new advances in medical and surgical treatment of epilepsy. Acute seizure management in a timely manner is crucial to prevent irreversible brain damage. Benzodiazepines still remain the first initial treatment to abort the seizure activity. The approval phenytoin, fosphenytoin, intravenous valproate, and rectal diazepam provided additional options. The approval of intravenous levetiracetam gave another option to physicians if and when the above treatment fails to control the seizure activity. In this Ebook, we have included chapters from renowned researchers in the field of neurology and epilepsy who have covered the various aspects of these agents in detail including the properties, mechanism of action, pharmacology, neurobehavioral effects, and the roles of these agents in special populations including traumatic brain injury and brain tumor related epilepsy. These data further show that intravenous levetiracetam can be used in acute seizure management and in special circumstances.
DO  - 10.3389/978-2-88919-322-6
ID  - OAPEN ID: 18584
KW  - Anticonvulsants
KW  - Treatment
KW  - Epilepsy
KW  - acute seizure management
KW  - levetiracetam
L1  - http://journal.frontiersin.org/researchtopic/1276/role-of-intravenous-levetiracetam-in-acute-seizure-management
LA  - English
LK  - https://directory.doabooks.org/handle/20.500.12854/58586
PB  - Frontiers Media SA
PY  - 2014
SN  - 9782889193226
TI  - Role of Intravenous Levetiracetam in Acute Seizure Managementnull
ER  - 
